Inter Pharma Public : Notification on the Offering Date of Newly-issued Ordinary Shares to Private Placement and Calculation of the Offering Price

IP_OCS/017/2565

	August 10th, 2022
Subject:	Notification on the Offering Date of Newly-issued Ordinary Shares to Private Placement and
	Calculation of the Offering Price
Attn:	The President
	The Stock Exchange of Thailand

In accordance to the Extraordinary General Meeting of Shareholders No. 1/2022 of Inter Pharma Public Company Limited ("the Company"), held on July 20th, 2022 has resolved to approve the capital increase of the Company including the allocation of newly-issued ordinary shares of 74,510,000 shares with a par value of 0.50 Baht per share by way of Private Placement to INNOBIC LL Holding Company Limited ("INNOBIC LL") which is not a connected person of the Company and the issuance of such newly-issued ordinary shares is a share offering where the Board of Directors' Meeting of the Company passed a resolution to clearly specify the offering price and propose to the Shareholders' Meeting to specify the offering price at 14 Baht per share, a total of 1,043,140 Baht, to which the offering price that is below 90% of the market price of the Company's shares according to the announcement TorJor. 72/2015. The market price is calculated from the weighted average price of the Company's ordinary shares on the stock exchange for the past 7 consecutive days before the date of the Board of Directors' resolution to propose to the Company's Shareholders' Meeting to approve the issuance and allocation of the Company's newly-issued ordinary shares to INNOBIC LL who is a private placement, during May 9th, 2022 to May 18th, 2022 which has a price equal to 18.67 Baht per share (Information from SETSMART at www.setsmart.com).

In this regard, the Company has received the approval to offer the newly-issued ordinary shares to the Private Placement under the Notification of the Market Supervisor Board No.TorChor. 72/2558 Re: The Approval for Offering of Newly-issued Shares to the Private placement from the Office of Securities and Exchange Commission on August 7, 2022.

On August 9th, 2022, the Board of Directors which was assigned by the Extraordinary General Meeting of Shareholders No. 1/2022 to approve the offering period, details of the said offering of newly-issued ordinary shares with time limit for subscription and payment for newly-issued ordinary shares on August 10th, 2022.

In compliance with the Notification of the Stock Exchange of Thailand Re: Rules, Conditions and Procedures for Consideration of Application for Listing of Ordinary Shares or Preferred Shares for Capital Increase as Listed Securities B.E. 2558 (2015), dated May 11, 2015 (as amended) (the "SET Notification"), the Company has demonstrated the market price of the Company's shares pursuant to the SET Notification for the previous 7 consecutive business days before the first day of offering the newly-issued ordinary shares to the Investors, which

บริษัท อินเตอร์ ฟาร์มา จ(มหาชน)ากัด เลขที่140/9 อาคารไอทีเอฟ ชัน้ 9 ถนนสีลม แขวงสุริยวงศ์ เขตบางรัก กรุงเทพมหานคร10500 โทรศัพท์ 02-634-0225 แฟ็ กซ์ 02-634-0135www.interpharma.co.thInter Pharma Public Company Limited 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawongse, Bangrak, Bangkok 10500, Thailand. Tel. [phone] Fax [phone]www.interpharma.co.th

is the period between August 1st - 9th, 2022 was equal to 18.06 Baht (Source: SETSMART via www.setsmart.com), with the details as follows:

No.	Date		Trading Volume	Trading Value
			(Shares)	(Baht)
1	9/8/2565		261,640	4.71
2	8/8//2565		112,531	2.02
3	5/8/2565		103,683	1.88
4	4/8/2565		132,656	2.40
5	3/8/2565		188,516	3.38
6	2/8/2565		87,385	1.59
7	1/8/2565		123,505	2.22
The weighted average price for 7 consecutive business days (Baht/share)	18.06
90 percent of the weighted average price for 7 consecutive business days	16.26
	(Baht/share)

In this regard, the offering price of the newly-issued ordinary shares at 14 Baht per share is the offering price that is below 90 percent of the market price of the Company's shares according to the regulations of the Stock Exchange of Thailand, which is equal to 16.26 Baht per share. Therefore, the issuance and allocation of newly-issued ordinary shares to investors is considered an offering of newly-issued shares at a low price and INNOBIC LL shares who have been allocated with 74,510,000 shares will be prohibited from selling their newly-issued ordinary shares for a period of 1 year from the date on which the Company's newly-issued ordinary shares begin trading on the SET (Silent Period) according to the SET announcement. After the date the newly-issued ordinary shares of the aforementioned company begins trading on the Stock Exchange of Thailand, after 6 months, they can gradually sell 25% of the prohibited shares.

Please be informed accordingly.

Yours sincerely,

(Dr. Trinnawat Thanitnithiphan)

Chief Executive Officer

บริษัท อินเตอร์ ฟาร์มา จ(มหาชน)ากัด เลขที่140/9 อาคารไอทีเอฟ ชัน้ 9 ถนนสีลม แขวงสุริวงศ์ เขตบางรัก กรุงเทพมหานคร10500 โทรศัพท์ 02-634-0225 แฟ็ กซ์ 02-634-0135www.interpharma.co.thInter Pharma Public Company Limited 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawongse, Bangrak, Bangkok 10500, Thailand. Tel. [phone] Fax [phone]www.interpharma.co.th